IOP Announces the Promotion of Jeffrey Sample to Quality Assurance Supervisor

Print This Post

IOP Announces the Promotion of Jeffrey Sample to Quality Assurance Supervisor

COSTA MESA, California – 27 October 2008 – IOP, Inc., the premier developer and distributor of specialty surgical technologies for eye surgery, announced today the promotion of Jeffrey Sample to Quality Assurance Supervisor. This new appointment is effective immediately.

jeff IOP Announces the Promotion of Jeffrey Sample to Quality Assurance Supervisor

Jeff initially joined IOP in 2005 as a customer service representative. He quickly established himself as a leader in customer care services and the management of customer-related issues. In 2006, he was promoted to Customer Service Supervisor. During Jeff’s tenure in customer service, IOP, Inc. experienced rapid, dramatic revenue and business growth. Concurrently, Sample demonstrated unyielding dedication and commitment to maintaining superior customer service in the face of such rapid expansion.

His new position with the company will allow IOP, Inc. to benefit from Jeffs’s focus, organization, and energy. He will be responsible for managing and supervising the company’s rapidly expanding quality systems and regulatory affairs.

Comments from Erich Ziegler, Vice President: “Jeff’s promotion is a result of his ability to think and act in concert with our quality needs. He’s earned the respect of IOP’s peers, customers and partners. He’s contributed significantly to IOP’s greatness. We are a blessed organization.”

Jeff, a resident of Tustin CA, is talented in his personal affairs as well – and is generally considered a great guy.

About IOP

Founded in 1988, IOP, Inc. develops and commercializes specialized, leading-edge surgical technologies for eye surgery. IOP’s purpose is to develop surgical solutions that improve the quality of life for patients, elevate the performance and productivity of eye care professionals, and lower costs to the provider.

IOP currently holds leadership positions with surgical devices for oculoplastic surgeries and bio-implant technologies for cornea, anterior and oculoplastic surgeries.

This entry was posted in News. Bookmark the permalink.

Author: admin

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>